title: Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses.
abstract: Vaccination with in vitro-generated dendritic cells (DC) that present tumor-associated antigens is a promising approach for immunotherapy of malignant tumors. For optimization of DC-based vaccination protocols, preclinical tumor models that mimic the clinical situation closely are highly desirable. Strong non-specific T cell activation was observed in experimental immunization of mice with syngeneic DC generated in standard FCS-supplemented culture medium. To avoid deviation of the immune response to FCS-derived antigens, a serum-free culture protocol for in vitro generation of murine DC from bone marrow progenitor cells was developed. In comparison to DC differentiated with FCS supplementation, DC generated under serum-free conditions (sfDC) have a more homogeneous phenotype with higher expression of IL-12 and the differentiation and activation markers CD11c, CD40, CD80, CD83, CD86, DEC-205, and MHC class II. Demonstration of strong uptake of protein and carbohydrate antigens and analysis of the in vivo migration behaviour of sfDC also indicated excellent APC function. Vaccination of mice with peptide-pulsed sfDC efficiently induced an antigen-specific T cell response as assessed by MHC tetramer staining, IFN-gamma ELISPOT and in vivo cytotoxicity assay. sfDC may therefore represent a valuable tool to improve active tumor immunotherapy in animal models.
authors.affiliation: Department of Hematology/Oncology, Freiburg University Medical Center, Germany.
authors.forename: Max
authors.initials: M
authors.lastname: Warncke
authors.forename: Anna
authors.initials: A
authors.lastname: Dodero
authors.forename: Heide
authors.initials: H
authors.lastname: Dierbach
authors.forename: Marie
authors.initials: M
authors.lastname: Follo
authors.forename: Hendrik
authors.initials: H
authors.lastname: Veelken
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation / Q000276:immunology; D016895:Culture Media, Serum-Free; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D005434:Flow Cytometry; D016130:Immunophenotyping; D016219:Immunotherapy, Adoptive / Q000379:methods; D007371:Interferon-gamma / Q000276:immunology; D018664:Interleukin-12 / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D018613:Microscopy, Confocal; D010446:Peptide Fragments / Q000276:immunology; D013047:Specific Pathogen-Free Organisms
chemical_list: D015703:Antigens, CD; D000951:Antigens, Neoplasm; D016895:Culture Media, Serum-Free; D010446:Peptide Fragments; D018664:Interleukin-12; D007371:Interferon-gamma